Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.
Read MoreSeralite® – FLC ELISA
Accurate measurement of both kappa and lambda free light chains (FLCs) across a diverse range of patient cohorts.
Read MoreClinical Utility
Clinicians are able to better understand disease status and can make informed decisions quickly and efficiently.
Read MoreTechnical Support
Contact us for sales assistance, technical support and further product information.
Read MoreHow to use a nucleic acid lateral flow immunoassay as an alternative to DNA agarose gel electrophoresis… https://t.co/BbByfZ1OwZ
24 July 2017
© Abingdon Health 2017
